Published Jun 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

Member News
Copy The Link to the  Article
Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development
Copy The Link to the  Article

Related or similar articles

View more News
December 10, 2021

Labshares Newton Doubles Space for Emerging Biotech Startups

NEWTON, Mass.--(BUSINESS WIRE)--Labshares Newton celebrated today the opening of 19,000 square feet of new incubator lab space and expects to open another 6,000-foot lab in September. Labshares’ new space incorporates 12 private suites, 15 lab ...
Labshares News
May 9, 2019

Labshares Newton Selects Savran Technologies as Winner of First Launch@Labshares Competition Valued at $50K

Second Launch@Shares Competition Announced in Collaboration with MTTC/MALSI Conference and MassBio’s MassCONNECT Program
Press Releases
October 9, 2024

A Fresh New Look at Labshares: Office Upgrade at 90 Bridge Street

Labshares News